BIOGRAPHY
John Worton, CEO and co-founder of Cannim, is a visionary leader in the global medical cannabis market. Raised in Jamaica and born in England, John and his brothers—William, Gregory, and James—have built Cannim into a fast-growing international powerhouse in the cannabis industry. Headquartered in Sydney, Australia, Cannim has farms across Australia, Canada, and Jamaica, and operates manufacturing facilities in Germany and Portugal, positioning itself as a key player in the global cannabis supply chain.
Under John’s leadership, Cannim is not only seizing opportunities in the expanding cannabis market but also redefining business models within the industry. The company’s global reach and innovative approach set it apart as a leader in medical cannabis production and distribution. John, alongside his brothers and CCO Marsh, has fostered a close-knit, family-style business culture that permeates the Sydney headquarters and extends across their international operations.
John Worton’s vision for Cannim is to drive the future of medical cannabis by scaling operations globally while maintaining a focus on quality, innovation, and patient care. With his leadership, Cannim is poised to continue its rapid growth, setting new benchmarks for success in the cannabis industry.
ABOUT Cannim
Founded in 2017 and based in Sydney, Australia, Cannim was established to bring the benefits of medicinal cannabis to the world. At a time when cannabis was still heavily stigmatized and cultivation considered more of an art than a science, Cannim built its foundation on three core pillars: Safety, Science, and Scale. The company’s mission was to demonstrate that cannabis is a legitimate medicine, consistently developed to pharmaceutical standards, and capable of reaching a broad audience of patients in need.
Cannim sources cannabis products from around the globe and has developed a robust network of EU GMP-certified manufacturers. This global reach allows the company to offer a wide variety of cannabis-based products and services, delivering relief to patients in many forms.
As a pioneer in the medicinal cannabis industry, Cannim is leading the charge in advancing cannabis as a reputable medicine. The company is at the forefront of research and education, exploring the effects of cannabis on a wide range of medical conditions. With an ever-growing user base, Cannim continues to scale its operations to meet the increasing demand while maintaining a commitment to patient access and fair pricing. Through innovation in product development and patient care, Cannim is shaping the future of medicinal cannabis and ensuring those in need receive the highest quality treatment when they need it.
